
    
      The study will be a multi-site, prospective, treatment-only post-market study of the H-TTS.
      The study will be performed in a commercial environment. Patients will already have a
      scheduled tympanostomy procedure with the H-TTS under moderate sedation and local anesthetic.
      A minimum of one hundred-sixty-seven (167) subjects will be included in the study at 5 sites.
    
  